Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial (Q34494637)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q60996888)
(Q6686665)
(P304) 761-775
(P407) (Q1860)
(P433) 7
(P478) 295
(P577) Wednesday, February 1, 2006
(P921) (Q12174)
(Q181600)
(Q17907844)
(Q422936)
(Q421237)
(P1433) (Q1470970)
(P1476) "Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial" (language: en)
(P2093) F Xavier Pi-Sunyer
Hassan M Heshmati
Jeanne Devin
RIO-North America Study Group
other details
description scientific article

External Links